252.3 📌 章末速蚘

252.3.0.0.1 Candida auris
  • WHO critical pathogen; 2009 emergence; multi-drug R
  • Hospital outbreaks; environmental persistence
  • Echinocandin first + AmB; AST essential
  • Contact precautions + cohorting
252.3.0.0.2 Fusarium
  • Neutropenic; disseminated with painful skin nodules; blood culture often+
  • Voriconazole + liposomal AmB combination
252.3.0.0.3 Lomentospora prolificans
  • Drowning + immunocompromise; very drug R; voriconazole partial; olorofim Phase 3
252.3.0.0.4 Trichosporon
  • Neutropenic disseminated yeast; cross-reacts cryptococcal antigen; voriconazole (echinocandins NOT)
252.3.0.0.5 Dematiaceous (Black) Fungi
  • Phaeohyphomycosis; pigmented hyphae (Fontana-Masson); itraconazole / voriconazole + surgery
252.3.0.0.6 Newer Drugs
  • Ibrexafungerp, fosmanogepix, olorofim — emerging
252.3.0.0.7 盧醫垫 hint
  • Nosocomial fungemia + multi-drug R → C. auris suspicion; MALDI-TOF + isolation
  • Neutropenic + disseminated with skin nodules → Fusarium; blood cx + voriconazole + AmB
  • Drowning + pneumonia → consider Scedosporium / Lomentospora